Back to Search
GERALD NACCARELLI, MD
MD
Cardiovascular Disease Physician
NPI: 1730137407IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
MD020752E(PA)
CMS Specialties
PrimaryCARDIAC ELECTROPHYSIOLOGY
Education
PENNSYLVANIA STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 1976
Research & Publications (20)
Vernakalant: pharmacology electrophysiology, safety and efficacy.
PMID 18548135·Drugs Today (Barc)·2008
6-review
Atrial fibrillation and the expanding role of catheter ablation: do antiarrhythmic drugs have a future?
PMID 18806600·J Cardiovasc Pharmacol·2008
6-review
Vernakalant--a promising therapy for conversion of recent-onset atrial fibrillation.
PMID 18447605·Expert Opin Investig Drugs·2008
6-review
New antiarrhythmic treatment of atrial fibrillation.
PMID 17605649·Expert Rev Cardiovasc Ther·2007
6-review
Does carvedilol have antiarrhythmic properties?
PMID 16265556·Nat Clin Pract Cardiovasc Med·2005
4-observational
Post myocardial infarction, left ventricular dysfunction, and the expanding role of cardiac implantable electrical devices.
PMID 16450813·Clin Cardiol·2005
6-review
Antiadrenergic therapy in the control of atrial fibrillation.
PMID 15965571·J Cardiovasc Pharmacol Ther·2005
6-review
Carvedilol's antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction.
PMID 15869048·Clin Cardiol·2005
6-review
Implantable cardioverter-defibrillators: expanding indications.
PMID 15218389·Curr Opin Cardiol·2004
6-review
Advances in the treatment of atrial fibrillation: the future is now.
PMID 14739743·J Interv Card Electrophysiol·2004
8-other
Atrial fibrillation in heart failure: prognostic significance and management.
PMID 15005215·J Cardiovasc Electrophysiol·2003
6-review
A review of clinical trials assessing the efficacy and safety of newer antiarrhythmic drugs in atrial fibrillation.
PMID 14574034·J Interv Card Electrophysiol·2003
6-review
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
PMID 12670638·Am J Cardiol·2003
6-review
Maintaining stability of sinus rhythm in atrial fibrillation: antiarrhythmic drugs versus ablation.
PMID 12169239·Curr Cardiol Rep·2002
6-review
The Brugada syndrome: clinical, genetic, cellular, and molecular abnormalities.
PMID 11343671·Am J Med·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 500 UNIVERSITY DR
HERSHEY, PA 17033 - Phone
- (800) 233-4082
Quick Facts
- NPI
- 1730137407
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 50
- Publications
- 20
Are you this provider?
Claim Your Profile